Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> UBS AG Latest News

22 HOURS AGO - Zero Hedge

A Must Read - Share

Frontrunning: September 30

Hong Kong protesters stockpile supplies, fear fresh police advance (Reuters) Protesters stay out on Hong Kong streets, defying Beijing (Reuters) Traders Turn Up Grilling Sausages at Hong Kong Protests (BBG) Ukraine Army Sees Worst Day Since Truce as Battles Flare (BBG) Islamic State uses grain to tighten grip in Iraq (Reuters) For Putin Ally, U.S. Sanctions Only Add to Anti-Russia ...

Tags: Frontrunning: September 30,  Ubs Ag Latest News

SEP 29, 2014 - Yahoo! News

A Must Read - Share

UBS eyes higher shareholder returns in new group structure: CFO

LONDON (Reuters) - A corporate structure unveiled by UBS AG on Monday will lead to higher shareholder returns in the long run, Chief Financial Officer Tom Naratil told Reuters. Switzerland's largest bank is creating a new group holding company in response to regulatory demands aimed at ensuring banks are easier to break up if they run into trouble. ...

Tags: UBS eyes higher shareholder returns in new group structure: CFO,  Ubs Ag Latest News

SEP 29, 2014 - Business Insider

A Must Read - Share

UBS Eyes Higher Shareholder Returns In New Group Structure: CFO

LONDON (Reuters) - A corporate structure unveiled by UBS AG on Monday will lead to higher shareholder returns in the long run, Chief Financial Officer Tom Naratil told Reuters.Switzerland's largest bank is creating a new group holding company in response to regulatory demands aimed at ensuring banks are easier to break up if they run into trouble."In the long run ...

Tags: UBS Eyes Higher Shareholder Returns In New Group Structure: CFO,  Ubs Ag Latest News

SEP 24, 2014 - TheStreet

A Must Read - Share

Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside

NEW YORK (TheStreet) -- Shares of Celgene are higher on Wednesday, after posting positive gains on Tuesday when many other stocks saw losses. Jim Cramer attributed these gains to the Food and Drug Administration'saapproval of the company's psoriasis treatment, which occurred Tuesday.a Must Read: 10 Stocks Carl Icahn Loves in 2014 On CNBC's "Cramer's Mad Dash" segment, Cramer, the co-manager ...

Tags: Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside,  Ubs Ag Latest News

SEP 23, 2014 - Zacks Investment Research

A Must Read - Share